Literature DB >> 15554876

Comparative analysis of the pathogenic mechanisms associated with the G8363A and A8296G mutations in the mitochondrial tRNA(Lys) gene.

Belén Bornstein1, José Antonio Mas, Clarice Patrono, Miguel Angel Fernández-Moreno, Emiliano González-Vioque, Yolanda Campos, Rosalba Carrozzo, Miguel Angel Martín, Pilar del Hoyo, Filippo M Santorelli, Joaquín Arenas, Rafael Garesse.   

Abstract

Two mutations (G8363A and A8296G) in the mtDNA (mitochondrial DNA) tRNA(Lys) gene have been associated with severe mitochondrial diseases in a number of reports. Their functional significance, however, remains unknown. We have already shown that homoplasmic cybrids harbouring the A8296G mutation display normal oxidative phosphorylation, although the possibility of a subtle change in mitochondrial respiratory capacity remains an open issue. We have now investigated the pathogenic mechanism of another mutation in the tRNA(Lys) gene (G8363A) by repopulating an mtDNA-less human osteosarcoma cell line with mitochondria harbouring either this genetic variant alone or an unusual combination of the two mutations (A8296G+G8363A). Cybrids homoplasmic for the single G8363A or the A8296G+G8363A mutations have defective respiratory-chain enzyme activities and low oxygen consumption, indicating a severe impairment of the oxidative phosphorylation system. Generation of G8363A cybrids within a wild-type or the A8296G mtDNA genetic backgrounds resulted in an important alteration in the conformation of the tRNA(Lys), not affecting tRNA steady-state levels. Moreover, mutant cybrids have an important decrease in the proportion of amino-acylated tRNA(Lys) and, consequently, mitochondrial protein synthesis is greatly decreased. Our results demonstrate that the pathogenicity of the G8363A mutation is due to a change in the conformation of the tRNA that severely impairs aminoacylation in the absence of changes in tRNA stability. The only effect detected in the A8296G mutation is a moderate decrease in the aminoacylation capacity, which does not affect mitochondrial protein biosynthesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15554876      PMCID: PMC1135008          DOI: 10.1042/BJ20040949

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

Review 1.  Mitochondrial respiratory chain disorders I: mitochondrial DNA defects.

Authors:  J V Leonard; A H Schapira
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

2.  Mitochondrial tRNALeu isoforms in lung carcinoma cybrid cells containing the np 3243 mtDNA mutation.

Authors:  A El Meziane; S K Lehtinen; I J Holt; H T Jacobs
Journal:  Hum Mol Genet       Date:  1998-12       Impact factor: 6.150

3.  A double mutation (A8296G and G8363A) in the mitochondrial DNA tRNA (Lys) gene associated with myoclonus epilepsy with ragged-red fibers.

Authors:  J Arenas; Y Campos; B Bornstein; R Ribacoba; M A Martín; J C Rubio; F M Santorelli; M Zeviani; S DiMauro; R Garesse
Journal:  Neurology       Date:  1999-01-15       Impact factor: 9.910

4.  Novel mitochondrial DNA mutation in tRNA(Lys) (8296A-->G) associated with diabetes.

Authors:  K Kameoka; H Isotani; K Tanaka; K Azukari; Y Fujimura; Y Shiota; E Sasaki; M Majima; K Furukawa; S Haginomori; H Kitaoka; N Ohsawa
Journal:  Biochem Biophys Res Commun       Date:  1998-04-17       Impact factor: 3.575

5.  A disease-associated G5703A mutation in human mitochondrial DNA causes a conformational change and a marked decrease in steady-state levels of mitochondrial tRNA(Asn).

Authors:  H Hao; C T Moraes
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

6.  Myoclonus epilepsy associated with ragged-red fibers: a G-to-A mutation at nucleotide pair 8363 in mitochondrial tRNA(Lys) in two families.

Authors:  M Ozawa; I Nishino; S Horai; I Nonaka; Y I Goto
Journal:  Muscle Nerve       Date:  1997-03       Impact factor: 3.217

7.  Modification defect at anticodon wobble nucleotide of mitochondrial tRNAs(Leu)(UUR) with pathogenic mutations of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.

Authors:  T Yasukawa; T Suzuki; T Ueda; S Ohta; K Watanabe
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

8.  The diabetes-associated 3243 mutation in the mitochondrial tRNA(Leu(UUR)) gene causes severe mitochondrial dysfunction without a strong decrease in protein synthesis rate.

Authors:  G M Janssen; J A Maassen; J M van Den Ouweland
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

9.  Search for differences in post-transcriptional modification patterns of mitochondrial DNA-encoded wild-type and mutant human tRNALys and tRNALeu(UUR).

Authors:  M Helm; C Florentz; A Chomyn; G Attardi
Journal:  Nucleic Acids Res       Date:  1999-02-01       Impact factor: 16.971

10.  Mitochondrial G8363A mutation presenting as cerebellar ataxia and lipomas in an Italian family.

Authors:  C Casali; G M Fabrizi; F M Santorelli; G Colazza; M Villanova; M T Dotti; T Cavallaro; E Cardaioli; C Battisti; L Manneschi; G C DiGennaro; D Fortini; M Spadaro; C Morocutti; A Federico
Journal:  Neurology       Date:  1999-03-23       Impact factor: 9.910

View more
  10 in total

Review 1.  Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases.

Authors:  Russell H Swerdlow
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

2.  The use of mitochondria-targeted endonucleases to manipulate mtDNA.

Authors:  Sandra R Bacman; Sion L Williams; Milena Pinto; Carlos T Moraes
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

3.  Mutations in the mitochondrial tRNA Ser(AGY) gene are associated with deafness, retinal degeneration, myopathy and epilepsy.

Authors:  Helen A L Tuppen; Karin Naess; Nancy G Kennaway; Mazhor Al-Dosary; Nicole Lesko; John W Yarham; Helene Bruhn; Rolf Wibom; Inger Nennesmo; Richard G Weleber; Emma L Blakely; Robert W Taylor; Robert McFarland
Journal:  Eur J Hum Genet       Date:  2012-02-29       Impact factor: 4.246

4.  Evolution meets disease: penetrance and functional epistasis of mitochondrial tRNA mutations.

Authors:  Raquel Moreno-Loshuertos; Gustavo Ferrín; Rebeca Acín-Pérez; M Esther Gallardo; Carlo Viscomi; Acisclo Pérez-Martos; Massimo Zeviani; Patricio Fernández-Silva; José Antonio Enríquez
Journal:  PLoS Genet       Date:  2011-04-21       Impact factor: 5.917

5.  Molecular dysfunction associated with the human mitochondrial 3302A>G mutation in the MTTL1 (mt-tRNALeu(UUR)) gene.

Authors:  Katharina Maniura-Weber; Mark Helm; Katrin Engemann; Sabrina Eckertz; Myriam Möllers; Matthias Schauen; Armine Hayrapetyan; Jürgen-Christoph von Kleist-Retzow; Robert N Lightowlers; Laurence A Bindoff; Rudolf J Wiesner
Journal:  Nucleic Acids Res       Date:  2006-11-27       Impact factor: 16.971

6.  Enhanced tumorigenicity by mitochondrial DNA mild mutations.

Authors:  Alberto Cruz-Bermúdez; Carmen G Vallejo; Ramiro J Vicente-Blanco; María Esther Gallardo; Miguel Ángel Fernández-Moreno; Miguel Quintanilla; Rafael Garesse
Journal:  Oncotarget       Date:  2015-05-30

Review 7.  Mitochondrial transcript maturation and its disorders.

Authors:  Lindsey Van Haute; Sarah F Pearce; Christopher A Powell; Aaron R D'Souza; Thomas J Nicholls; Michal Minczuk
Journal:  J Inherit Metab Dis       Date:  2015-05-28       Impact factor: 4.982

8.  The pathogenicity scoring system for mitochondrial tRNA mutations revisited.

Authors:  Emiliano González-Vioque; Belén Bornstein; María Esther Gallardo; Miguel Ángel Fernández-Moreno; Rafael Garesse
Journal:  Mol Genet Genomic Med       Date:  2013-11-11       Impact factor: 2.183

9.  Whole Mitochondrial Genome Analysis in Turkish Patients with Mitochondrial Diseases

Authors:  Emine Begüm Gencer Öncül; Duygu Duman; Fatma Tuba Eminoğlu; Süleyman Aktuna; Mustafa Türker Duman
Journal:  Balkan Med J       Date:  2021-12-20       Impact factor: 2.021

10.  Mitochondrial targeting of recombinant RNAs modulates the level of a heteroplasmic mutation in human mitochondrial DNA associated with Kearns Sayre Syndrome.

Authors:  Caroline Comte; Yann Tonin; Anne-Marie Heckel-Mager; Abdeldjalil Boucheham; Alexandre Smirnov; Karine Auré; Anne Lombès; Robert P Martin; Nina Entelis; Ivan Tarassov
Journal:  Nucleic Acids Res       Date:  2012-10-18       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.